Literature DB >> 30663833

Fibromyalgia: A misconnection in a multiconnected world?

Serge Perrot1.   

Abstract

Fibromyalgia represents a condition still controversial in its entity, pathophysiology, diagnosis and management (Figure ). In a world where everybody is connected, and everybody is sharing their own image, fibromyalgia (FM) represents the emblematic pathology of misconnection and lack of specific biomarker. FM is an invisible experience with all normal tests and analyses, without any visible biomarker to exhibit to healthcare professionals, colleagues and relatives. In this context, we propose to consider FM as a disease of misconnection at different levels: misconnection with society, misconnection with healthcare professionals, misconnection with pathophysiological concepts, misconnection between brain and body. The concept of misconnection defines FM in a different and holistic view and proposes different views of assessment, management and representation: FM pathophysiology: the desynchronization of brain and body FM recognition: the broken link between patients and physicians FM assessment: merging the body and mind for an optimal diagnosis and management FM treatment: re-establishing the good connections at different levels We hope to reconnect FM patients with all healthcare providers, help FM patients reconnect with their painful body and integrate FM into regular medical practice. SIGNIFICANCE: The concept of misconnection defines FM in a different and holistic view, and propose different views of assessment, management and representation.
© 2019 European Pain Federation - EFIC®.

Entities:  

Mesh:

Year:  2019        PMID: 30663833     DOI: 10.1002/ejp.1367

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  6 in total

Review 1.  Milnacipran for the Treatment of Fibromyalgia.

Authors:  Harshit Gupta; Brook Girma; Jack S Jenkins; Sarah E Kaufman; Christopher A Lee; Alan D Kaye
Journal:  Health Psychol Res       Date:  2021-07-10

2.  Osteopathic medicine for fibromyalgia: a sham-controlled randomized clinical trial.

Authors:  Joël Coste; Terkia Medkour; Jean-Yves Maigne; Marc Pérez; Françoise Laroche; Serge Perrot
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-04-16       Impact factor: 5.346

Review 3.  Research in Mindfulness Interventions for Patients With Fibromyalgia: A Critical Review.

Authors:  Salomé Leça; Isaura Tavares
Journal:  Front Integr Neurosci       Date:  2022-07-28

Review 4.  Pathophysiologic Approach to Pain Therapy for Complex Pain Entities: A Narrative Review.

Authors:  Martina Rekatsina; Antonella Paladini; Alba Piroli; Panagiotis Zis; Joseph V Pergolizzi; Giustino Varrassi
Journal:  Pain Ther       Date:  2020-01-04

5.  Metabolomic and proteomic characterization of sng and pain phenotypes in fibromyalgia.

Authors:  Wei-Hsiang Hsu; Der-Sheng Han; Wei-Chi Ku; Yen-Ming Chao; Chih-Cheng Chen; Yun-Lian Lin
Journal:  Eur J Pain       Date:  2021-10-26       Impact factor: 3.651

6.  Experiences of Patient-Led Chronic Pain Peer Support Groups After Pain Management Programs: A Qualitative Study.

Authors:  Michelle Farr; Heather Brant; Rita Patel; Myles-Jay Linton; Nicholas Ambler; Sareeta Vyas; Hannah Wedge; Sue Watkins; Jeremy Horwood
Journal:  Pain Med       Date:  2021-12-11       Impact factor: 3.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.